ANGIOCEPT, created in 2008 (United States), from 496 sister brands and 17477 competing brands. ANGIOCEPT is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York ANGIOCEPT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(ANGIOCEPT)
over 5 years*
USD 51.82